- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418482
Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns
An Open Non-controlled Post-marketing Investigation Evaluating the Experience of Using a Self- Adherent Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns
Study Overview
Detailed Description
At baseline, subject characteristics will be registered together with subject status of health and status of the burn, and current treatment of the burn.
At each visit the following variables will be collected where applicable:
Investigator's/Nurse evaluation of
- Overall experience of the dressing
- Ability of dressing to stay in place (not at baseline)
- Conformability of the dressing
- Handling at application
- Ease of removal of the dressing (not at baseline)
Subject evaluation of
- Overall experience of the dressing
- Comfort of the dressing
- Conformability of the dressing
- Pain before, during and after removal of dressing according to VAS
- Status of skin
- Burn status: width x length, exudate details and signs of inflammation/infection
In addition the following variables should be evaluated at each visit:
- Concomitant medication/treatment
- Adverse Event/Adverse Device Effect (AE/ADE)
- Serious Adverse Event/Serious Adverse Device Effect (sAE/sADE)
Photos will be taken before Mepilex Border Ag is removed, after removal, before cleansing, and after cleansing. All photos must include a sticker marker with subject code, visit number and date, and an indication of whether pre-/post removal, pre-/post cleansing. The stick marker also contains a ruler. Detailed instructions on how to take the photos is given in Appendix 14.2
At each visit the subject will give the assessment concerning the comfort and stay-on-ability of the dressing. The investigator will also give an assessment at each visit concerning handling, conformability and ability of dressing to stay in place.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Linköping, Sweden
- Briva/Hpk
-
Uppsala, Sweden
- Plastikkirurgiska kliniken, UAS BRIVA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject with a small partial thickness burn (< 9.5x15 cm) where an antimicrobial action is indicated as judged by the investigator*
- Male or female, 18 years and above, both in- and out-patient subjects
- Signed Informed Consent Form
Exclusion Criteria:
- Wound size equal to or above 9.5x15cm for the selected burn for the investigation
- Pregnant and/or breastfeeding women
- Subject not expected to follow the investigation procedures or applicable for investigation according to the judgment of the investigator
- Subjects with known sensitivity to silver or any other contents of the dressing
- Subjects previously included in this investigation
- Subjects included in other ongoing clinical investigation at present or during the past 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mepilex Border Ag
Mepilex Border Ag, a silver dressing will be used
|
a silver dressing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the Experience of Using Mepilex Border Ag ( a Silver Dressing) in Normal Clinical Practice
Time Frame: 3 weeks
|
burns healed
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the Comfort
Time Frame: 3 weeks
|
Comfort level and overall experience were each assessed using a scale that ranged from very poor to very good.
|
3 weeks
|
Pain
Time Frame: 3 weeks
|
To evaluate pain during dressing removal at visit 4,(after one week) with John Hopkins pain scale.
Measured 0=no pain, 100= worst pain, scale from 0-100 mm
|
3 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fredrik Huss, MD, Akademiska hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MxB Ag 02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
MediWound LtdCompletedThermal BurnsUnited States, Israel, Belgium, Czechia, Georgia, Germany, Italy, Romania
-
Sun Yat-sen UniversityCompleted
-
MediWound LtdActive, not recruitingThermal BurnsUnited States, United Kingdom, Spain, Georgia, Belgium, Poland, Germany, Hungary, India, Italy, Netherlands, Romania, Slovakia, Ukraine
-
Virginia Commonwealth UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
St. Justine's HospitalRecruiting
Clinical Trials on Mepilex Border Ag
-
Melbourne HealthCompleted
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABCompletedArthroplasties, Hip Replacement | Arthroplasties, Knee ReplacementUnited States
-
Molnlycke Health Care ABCompleted
-
PD Dr. Jan KottnerCompletedPressure UlcerGermany
-
Molnlycke Health Care ABCompletedPressure Incidence PreventionUnited States
-
ConvaTec Inc.CompletedLeg UlcersUnited Kingdom
-
Molnlycke Health Care ABRecruiting
-
Molnlycke Health Care ABCompletedVenous Leg Ulcers | Mixed Leg UlcersFrance, Germany, Netherlands, Czech Republic
-
Taipei Medical University Shuang Ho HospitalUnknown